Treadwell Therapeutics is a clinical-stage oncology company exploiting cancer cells' vulnerabilities to develop first-in-class and best-in-class small molecules to address unmet needs in patients with cancer.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/13/20 | $27,000,000 | Seed |
TIO Bioventures | undisclosed |
